Digital PCR (dPCR) Market - Forecast (2020 - 2025)

Digital polymerase chain reaction (dPCR) is used to divide a sample of DNA or cDNA. Growing governmental initiatives in implementing better molecular diagnostic methods in diseases diagnosis is anticipated to foster the growth of the dPCR market. The digital polymerase chain reaction (dPCR) market was valued at $278.9m in 2020 and is estimated to reach $819.5m by 2025, growing at a CAGR of 19.89% during the forecast period 2020–2025. Europe holds the largest share in the market followed by Asia-Pacific owing to the rising geriatric population in these regions. Asia-Pacific is projected to witness the fastest growth during the forecast period owing to the rising R&D expenditure in the life sciences sector in various developing countries such as China and India.

Digital PCR Market Outlook

Digital polymerase chain reaction (dPCR), an advancement of traditional PCR, is used to detect and quantify DNA or a targeted part of DNA molecule. It distributes a sample of DNA or complementary DNA into many individual, parallel PCR reactions. It is used in various types of applications such as DNA cloning, diagnosis of hereditary diseases, functional analysis of genes, paternity testing, detection of infectious diseases, and forensic sciences. Its high precision, high tolerance to inhibitors, and high capacity to analyze complex combinations of DNA are some of the factors driving the dPCR market. The dPCR market is expected to grow globally due to the increase in number of infectious diseases and genetic disorders.

Digital PCR Market Growth Drivers

The growing demand for Digital PCR (dPCR) is due to the rapid technological advancements, increasing awareness about the benefits of early diagnosis of hereditary and infectious diseases, and growing demand for parental testing and gene study. The growing awareness among people regarding infectious diseases is significantly contributing to the growth of the digital PCR market. Technological improvements in medical applications is estimated to drive the dPCR market during the forecast period.

Digital PCR Market Challenges

Manufacturers need high initial costs in order to manufacture digital PCR system. In addition to this, high final device costs and technical limitations in digital PCR system, such as limited range of detection, are restraining the Digital PCR Market growth. Insufficient number of researchers and skilled laborers, and lack of proficient data analysis tools are hindering the market growth. Growing implementation of minimum information for publication of Quantitative Digital PCR Experiments for the independent evaluation of experimental data and comprehensive disclosure of all relevant details is challenging the market growth. Also high installation costs associated with dPCR is expected to restrain the growth of the dPCR market during the forecast period. 

Digital PCR Market Research Scope

The base year of the study is 2020, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the digital pcr in healthcare market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types and end users of Digital PCR, and their specific applications in the healthcare industry.

Digital PCR Market Report: Industry Coverage

• Types of Digital PCR: Droplet dPCR, BEAMing dPCR

• Product and Service type of Digital PCR: Instruments, Reagents and Consumables, Software and Services

- Application of Digital PCR: Clinical, Research, Forensic

• End Users of Digital PCR: Hospital, Diagnostic Center, Academia, Pharma-Biotech Co.

Digital PCR market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions.

The regions and countries covered in the study include:

• North America: The U.S., Canada, Mexico

• South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

• Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

• APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

• The Middle East and Africa: Israel, South Africa, Saudi Arabia

Digital PCR Market Key Players Perspective

Some of the key players mentioned in this market research report include Thermo Fisher Scientific Inc. (the U.S.), Bio-Rad Laboratories, Inc. (the U.S.), RainDance Technologies, Inc. (the U.S.), Fluidigm Corporation (the U.S.), JN Medsys (Singapore), and Formulatrix Inc. (the U.S.).

Digital PCR Market Trends

• Companies engaged in the Digital PCR market focused on product launches and acquisitions, which together accounted for 71.4% of the total development in 2020. Qiagen, Thermo Fisher Scientific, and Formulatrix are a few companies that employed acquisition strategies in the recent years.

• Companies are also entering into new partnership agreements to open up new avenues in product development and achieve greater market exposure.

• The clinical application segment of the digital PCR (DPCR) market accounted for $151.7m of the market share in 2020 and is projected to reach $471.2m by 2025, exhibiting a healthy CAGR of 21.01% during the forecast period.

• Hospitals are the major end-users of digital PCR (dPCR), accounting for 50% share of the end user segment of dCPR market in 2020 owing to the increasing diagnosis of several diseases at early stages with increasing recovery rate.

• As per analysis, the Americas region was the largest market for digital PCR (DPCR) with a share of 46% of the market in 2020, and the value is estimated to reach $360.6m by 2025 owing to the rising cancer cases.